Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study

Shannon E Telesco1, Ravi Radhakrishnan

  • 1Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Biophysical Journal
|March 18, 2009
PubMed

Insights

Molecular dynamics simulations reveal how HER2 (ErbB2/Neu) kinase activation is regulated. Phosphorylation of tyrosine 877 and dimerization with EGFR stabilize the active HER2 conformation, crucial for breast cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • HER2 (ErbB2/Neu) is a receptor tyrosine kinase overexpressed in 20-30% of breast cancers.
  • The precise activation mechanism of HER2 remains unknown, with a unique proposed requirement for Y877 phosphorylation.

Purpose of the Study:

  • To elucidate mechanistic details of HER2 kinase domain regulation.
  • To understand the role of Y877 phosphorylation and HER2/EGFR heterodimerization in kinase activation.

Main Methods:

  • Molecular dynamics simulations of homology-modeled HER2 kinase structures.
  • Principal component analysis of atomistic fluctuations.
  • Free energy perturbation calculations.

Main Results:

  • A tight coupling between the activation and catalytic loops in HER2 was identified.
  • Phosphorylated Y877 is predicted to stabilize active kinase conformations.
  • HER2/EGFR heterodimerization induces alphaC helix rearrangement towards an active conformation.

Conclusions:

  • Elucidation of HER2 regulatory mechanisms aids in understanding wild-type kinase function.
  • Insights can predict mutations leading to constitutive activation in HER2-mediated cancers.